GCC Functions and Penetration
- Finance: 70%
- Human Resources: 75%
- Supply Chain: 62%
- IT Functions: 67%
- Drug Discovery & Development: 45%
- Regulatory Affairs: 60%
- Medical Affairs: 54%
- Commercial Operations: 50%
Arindam Sen, Partner and GCC Sector Lead at EY India, noted:
“Life sciences multinationals are embedding their most strategic, knowledge-intensive work here, making India the epicentre for life sciences innovation, compliance, and future growth.”
Expanding Role in Core Functions
The report highlights India’s transition from a support base to a centre of innovation for global pharma and healthcare. Life sciences GCCs now lead clinical trials, pharmacovigilance, regulatory affairs, supply chain management, and other critical functions, delivering stronger enterprise outcomes.
Advanced areas such as drug discovery, digital therapeutics, real-world evidence analytics, and AI-driven innovation are increasingly being managed from India, emphasizing the country’s strategic role beyond cost arbitrage.
Drivers of Growth
- Policy support: State and central governments promoting GCCs as engines of digital exports and job creation.
- Talent pool: 2.7 million life sciences professionals.
- Startup ecosystem: Over 100 unicorns contributing to innovation.
- Infrastructure: Abundant Grade-A commercial spaces across metros and emerging Tier-II and Tier-III cities.
The Next Phase
- Future-ready capabilities
- Outcome-focused operating models
- AI-ready, multi-disciplinary talent pool
Read more full news: Here
